Abstract-Behavioral effects of 6R-L-erythro-5,6,7,8-tetra hydrobiopterin (R THBP), a co-factor for tyrosine hydroxylase and tryptophan hydroxylase, were investigated by means of ambulatory activity in mice. Single administration of R THBP (50 and 100 mg/kg, s.c.) showed no significant effect on the mouse's ambulatory activity for 5 hr. The ambulation-increasing effect of methamphetamine (2 mg/kg, s.c.) was dramatically enhanced and prolonged by the pretreatment with R-THBP (100 mg/kg, s.c.) 0, 2, 6, 12 and 24 hr before, but not 18 or 36 hr before, the methamphetamine administration. However, when combined administration of R-THBP (100 mg/kg, s.c., 2 hr before) with methamphetamine (2 mg/kg, s.c.) was repeated at intervals of 3-4 days, the enhancement by R-THBP of the methamphet amine effect was observed only in the 1st and 2nd administration, but not in the
Abstract-Behavioral effects of 6R-L-erythro-5,6,7,8-tetra hydrobiopterin (R THBP), a co-factor for tyrosine hydroxylase and tryptophan hydroxylase, were investigated by means of ambulatory activity in mice. Single administration of R THBP (50 and 100 mg/kg, s.c.) showed no significant effect on the mouse's ambulatory activity for 5 hr. The ambulation-increasing effect of methamphetamine (2 mg/kg, s.c.) was dramatically enhanced and prolonged by the pretreatment with R-THBP (100 mg/kg, s.c.) 0, 2, 6, 12 and 24 hr before, but not 18 or 36 hr before, the methamphetamine administration. However, when combined administration of R-THBP (100 mg/kg, s.c., 2 hr before) with methamphetamine (2 mg/kg, s.c.) was repeated at intervals of 3-4 days, the enhancement by R-THBP of the methamphet amine effect was observed only in the 1st and 2nd administration, but not in the It is known that 5,6,7,8-tetrahydrobiopterin (THBP) is a natural co-factor for tyrosine hy droxylase (1) and tryptophan hydroxylase (2) , rate-limiting enzymes in the biosynthesis of catecholamines and indoleamine, respec tively. It has been reported that an alteration of THBP metabolism is responsible for the rare childhood disease of THBP-deficient hyper phenylalaninemia, which is also related to an atypical phenylketonuric disease (PKU) (3). Additionally, deficits of THBP metabolism have been demonstrated in various types of neurological and psychiatric diseases includ ing Parkinson's disease (4, 5), familial dys tonia (6, 7), endogenous depression (8) , in fantile autism (9) , etc.; and therapeutic trials with peripheral administration of THBP have been initiated in these diseases with limited success (3) (4) (5) (6) (7) (8) (9) .
In animal studies, the THBP content in the whole rat brain increases for 2 hr after i.p. ad ministration of a comparatively higher dose of THBP, although only a small percentage of peripherally-administered THBP enters into the brain (10) . A natural isomer of THBP, 6R L-erythro-5,6,7,8-tetrahydrobiopterin (R-TH BP), has been demonstrated to penetrate the blood-brain barrier more effectively than TH BP (11, 12) . It has been also reported that intraventricular injection of R-THBP elicits not only significant increases in the activities of both tyrosine hydroxylase and tryptophan hy droxylase, but also increases in dopamine and serotonin metabolisms (11) . In these respects, R-TH BP seems to play an important role in the function of the central nervous system. How ever, characteristics of the central effect of R THBP have not been known when this drug is peripherally administered.
The purpose of this research was to con duct a behavioral study on the effects of R THBP by means of ambulatory activity in mice. In this experiment, R-THBP was admin istered singly or repeatedly and combined with several central-acting drugs, all of which increase mouse's ambulatory activity through direct or indirect stimulation of central cate cholaminergic systems.
Materials and Methods 1 Animals
The experimental animals used were male mice of the ddY strain (Japan Laboratory Animal), which were provided at 5 weeks of the age. The groups of 10 mice had been housed in aluminum cages of 30 (W)x20 (D) x 10 (H) cm with a wooden-flake floor mat (White Flake: Charles River Japan, Inc.) and given food and tap water ad libitum until the start of the experiment. The breeding room was controlled in illumination (light period: 6:00-18:00) and temperature (22±2 °C). The experiment was conducted when the mice were 7 weeks of age and weighed 28-35 g.
Apparatus
The apparatus for measurement of the mouse's ambulatory activity was a tilting type ambulometer (AM B-10: O'hara & Co.) (13). The apparatus consisted of 10 bucket like activity cages, each of which was made of plexiglas and had a diameter of 20 cm. There by, the ambulatory activities of 10 mice could be measured individually at the same time.
Drugs and administration schedules
The drugs used were R-THBP (Suntory), methamphetamine HCI (Philopon, Dainippon Pharm.), ephedrine HCI (Dainippon Pharm.), cocaine HCI (Takeda Chem.), mazindol (Sandoz), bromocriptine mesylate (Sandoz), morphine HCI (Takeda Chem.) and scopol amine HBr (Sigma Chem.). Except for mazin dol and bromocriptine, the drugs were dis solved in physiological saline. Mazindol was first dissolved in a small volume of 0.1 N HCI solution, then diluted by physiological saline. Bromocriptine was dissolved in physiological saline with one drop of Tween 80 per 3 ml. The concentration of each drug solution was adjusted so that each volume administered was always constant at 0.1 ml/10 g body weight regardless of the drug doses. Since R THBP dossolved in water was unstable, the solution was used within 1 min after its prep aration. 1) Single administration R-THBP alone: Mice were individually put into activity cages, and after an adaptation period of 30 min, R-THBP at 50 or 100 mg/kg or physiological saline was administered s.c. The ambulatory activity of each mouse was observed for 5 hr thereafter.
Combination of R-THBP with metham phetamine: Four experiments were conducted to observe interactions between R-THBP and methamphetamine.
a) R-THBP at 50 or 100 mg/kg or phys iological saline was administered s.c. to mice; and 2 hr later, the mice were treated with methamphetamine at 2 mg/kg, s.c. b) R-THBP at 100 mg/kg or saline was first administered to mice, and 2 hr after the dosing, the mice were treated with metham phetamine at 0.5, 1 or 2 mg/kg, s.c. c) R-THBP at 100 mg/kg or saline was first administered to 14 groups of mice. Each group of mice treated with R-THBP or saline were given methamphetamine at 2 mg/kg with a time span of either 0 (simultaneous ad ministration), 2, 6, 12, 18, 24 or 36 hr. To avoid a circadian variation in the methamphet amine sensitivity (14), the time-of-day of R THBP administration was adjusted so that the mice were always given methamphetamine between 12:00-12:30 of the light period. d) Mice were first treated with metham phetamine at 2 mg/kg, s.c.; and 4 hr after the dosing, they were given R-THBP at 100 mg/ kg, s.c.
Combination of R-THBP with other central-acting drugs: R-THBP at 100 mg/kg or saline was first administered s.c.; and 2 hr after the dosing, it was followed by treatment with second dosing of one of ephedrine, 80 mg/kg, i.p.; cocaine, 20 mg/kg, s.c.; mazindol, 2.5 mg/kg, s.c.; bromocriptine, 8 mg/kg, i.p.; morphine, 20 mg/kg, s.c.; and scopolamine, 0.5 mg/kg, s.c. After the second dosing, the mouse's ambulatory activity was observed for 2 to 6 hr depending on the drugs. The doses and administration routes of methamphet amine, ephedrine, cocaine, mazindol, bromo criptine, morphine and scopolamine employed in this experiment were taken to be optimum to adequately increase ambulatory activity in mice according to our previous investigations (13, 15-18). 2) Repeated administration R-THBP alone: R-THBP at 50 or 100 mg/kg or saline was administered s.c. 5 times at intervals of 3-4 days, and the mouse's ambulatory activity was observed for 5 hr after each administration.
Combination of R-THBP with meth amphetamine:
Repeated methamphetamine administration elicits a reverse tolerance to its ambulation-increasing effect. We studied the effect of R-THBP on the reverse tolerance to methamphetamine.
Mice were first treated with R-THBP at 50 or 100 mg/kg or saline, s.c.; and 2 hr later, they were given metham phetamine at 2 mg; kg, s.c. The same treat ment was conducted 5 times at intervals of 3-4 days. 4 Urinary pH level Just before and 5 hr after the administration of R-THBP (100 mg/kg, s.c.) or saline, the urinary pH levels of mice were measured by bromothymol blue test-paper (Toyo Filter Paper). During the observation period, food and water were removed from the cages.
Statistical analyses
Statistical comparisons of the mean am bulatory activity counts or mean urinary pH levels were conducted using Student's t-test. The number of mice that died after R-THBP were compared using the x-square test.
When P values were equal to or less than 0.05, they were taken to indicate a significant difference.
Results

1) Single administration
R-THBP alone: The administration of R THBP (50 or 100 mg/kg) alone produced no significant change in the mouse's ambula tory activity for 5 hr (data not shown), be cause the baseline activity of saline-treated control mice showed much lower activity throughout the observation period.
Combination of R-THBP with metham phetamine: a) Figure 1 shows the time-course of changes in the ambulatory activity in the mice that were treated with the combination of R-THBP and methamphetamine. In the saline-pretreated control mice, methamphet amine increased the ambulatory activity for 3 hr, with the maximum effect at about 1 hr after the administration. The pretreatment with R-THBP at 50 mg/kg failed to modify the am bulation-increasing effect of methamphet amine. However, the effect of methamphet amine was markedly enhanced and prolonged by R-THBP at 100 mg/kg. b) Figure 2 shows the mean overall am bulatory activity counts after administration of methamphetamine at 0.5, 1 and 2 mg/kg to the mice that were pretreated with R-THBP at 100 mg/kg or saline 2 hr before. Metham phetamine scarcely increased the mouse's ambulatory activity at 0.5 mg/kg, while it dose-dependently increased the activity at 1 and 2 mg/kg. Although R-THBP at 100 mg/ kg did not modify the effect of methamphet amine at 0.5 mg/kg, it enhanced the ambu lation-increasing effect of methamphetamine at 1 and 2 mg/kg. c) Figure 3 shows the mean overall am bulatory activity counts for 5 hr after the ad ministration of 2 mg/kg of methamphetamine to mice that had been pretreated with R-TH B P at 100 mg/kg or saline at 0, 2, 12, 18, 24 or 36 hr before methamphetarnine.
There was no significant difference in the ambulatory ac tivity counts among the 7 saline-treated groups. The pretreatment with R-THBP at 0, 2, 6, 12 and 24 hr before, but not at 18 and 36 hr before, were effective for enhancing the ambulation-increasing effect of methamphet amine. The maximum enhancement was ob served when R-THBP was pretreated at 2 hr before.
d) The ambulation-increasing effect of methamphetamine almost abolished 4 hr Fig. 2 . Mean overall ambulatory activity counts for 5 hr after administration of methamphetamine (0.5, 1 or 2 mg/kg, s.c.) in the mice that were pretreated with R-THBP (100 mg/kg, s.c.) or saline 2 hr before the methamphetamine administration. *: significant difference compared to the saline-pretreated control value (P<0.05). Each figure in parenthesis indicates number of mice used. Fig. 3 . Mean overall ambulatory activity counts for 5 hr after administration of meihamphetamine (MAP: 2 mg/kg, s.c.) in the mice that were pretreated with saline or R-THBP (100 mg/kg, s.c.) at 0, 2, 6, 12, 18, 24 or 36 hr before MAP administration. *: significant difference compared to the saline-treated control value (P<0.05).
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after the administration. When R-THBP at 100 mg/kg was administered 4 hr after meth amphetamine, the mice did not show any in crease in the ambulatory activity (data not shown).
Combination of R-THBP with central acting drugs: Figure 4 shows time-course changes in the ambulatory activity counts after the administration of ephedrine, 80 mg/ kg (i.p.); cocaine, 20 mg/kg (s.c.); mazindol, 2.5 mg/kg (s.c.); bromocriptine, 8 mg/kg (i.p.); morphine, 20 mg/kg (s.c.); and scopol amine, 0.5 mg/kg (s.c.) in the mice that were pretreated with R-THBP at 100 mg/kg (s.c.) or saline (s.c.) 2 hr before each drug admin istration. The doses of these drugs were taken from our previous experiments (13-16). Al though the grade and duration of the effects were different among the drugs, all of them increased the mouse's ambulatory activity. R THBP specifically enhanced the ambulation increasing effect of ephedrine, but those of cocaine, mazindol, bromocriptine, morphine and scopolamine were not modified by R TH B P. reverse tolerance, an enhancement of the sensitivity, to the ambulation-increasing ef fect. R-THBP at 50 mg/kg hardly modified the process of reverse tolerance. In the case of the combination of 100 mg/kg of R-THBP and methamphetamine, the activity counts in the 1st and 2nd administrations were signifi cantly higher as compared with methamphet amine alone. However, the activity counts in the later administrations were almost the same as those of the mice given methamphetamine alone (Fig. 5). 3) General symptoms Table 1 shows occurrences of dead mice within 24 hr after the drug treatments. R THBP at 100 mg/kg, but not 50 mg/kg, showed a lethal effect, eliciting the death of 4/30 (13%) mice. The occurrence of dead mice distributed between 0% (treatment with R-THBP+ MAP, 0.5 mg/kg; R-THBP+ REPEATED COMBINED ADMINISTRATION OF R-THBP & MAP Fig. 5 . Changes in mean overall ambulatory activity counts in mice during the 5 hr observation after repeated combined administration of R-THBP (0 , 50 or 100 mg/kg, s.c.) and methamphetamine (MAP: 2 mg/kg, s.c.). The experiment was conducted 5 times at intervals of 3-4 days. In each experiment, saline and R-THBP were administered 2 hr before MAP administration . *: significant difference as compared to the saline-pretreated control value (P<0.05). mazindol; and R-THBP+scopolamine) and 35% (R-THBP+ephedrine).
However, these occurrence rates were not significantly dif ferent from that observed after treatment with R-THBP (x-square test). The surviving mice also exhibited severe general symptoms that were characterized by a decrease in body weight, a mild tremor, a bad coat of hair, etc. These symptoms attained a maximum level at 18-24 hr and persisted for 2-3 days.
The control mice showed a body weight gain of 5.6 g during the experimental period of repeated administration.
The mice repeat edly treated with R-THBP at 50 mg/kg showed no remarkable change of their body condition throughout the administration peri od. However, at 100 mg/kg, 4/20 and 1/16 mice died after the 1st and 2nd administra tions, respectively, but after the 3rd-5th ones, no mice died. Although the surviving mice failed to gain body weight after the 1st and 2nd administrations, their body weight tended to be at the initial level until the 4th adminis tration. 4) Urinary pH level R-TH BP did not modify the mouse's urinary pH level (data not shown). Discussion R-THBP is the natural isomer of THBP, a co-factor for tyrosine hydroxylase and tryp tophan hydroxylase (10, 12) . Therefore, it is primarily expected that a single dosing of R TH BP may markedly stimulate the central catecholaminergic systems and is effective to increase the mouse's ambulatory activity like that observed after stimulant drugs. However, the first experiment of our study showed that R-THBP alone failed to modify the ambulatory activity at 100 mg/kg, but demonstrated a lethal effect. Miller et al. (19) reported that the administration of THBP at 20 mg/kg, i.v. did not modify the metabolism of monoamines in the brain of the monkey, although the drug was detected for 15 hr with the maximum concentration at 1.5-2 hr in the cerebrospinal fluid. Levine et al. (20) also observed a similar result in rats at 50 mg/kg, i.p. It might be therefore reasonable that peripherally admin istered R-THBP alone scarcely shows a clear central effect even at sublethal to lethal doses. The lethal effect may be caused by non specific action.
To investigate the possibility that R-THBP may have a central effect, we conducted combined administration of R-THBP with typical central-acting drugs. The pretreatment with R-THBP at 50 mg/kg scarcely modified the ambulation-increasing effect of meth amphetamine.
However, it is notable that R THBP at 100 mg/kg enhanced the effect of methamphetamine.
This result indicates that a comparatively higher dose of R-THBP is required to modify the ambulation-increasing effect of methamphetamine and that R THBP's effect persists approximately 24 hr. The present experiment demonstrated that the effect of R-THBP attained the maximum level at about 2 hr after its administration. This result is consistent with the metabolic data on THBP by Miller et al. (19) .
It has been well-known that a change in the urinary pH level is closely related to the sensitivity to methamphetamine (21, 22) , because urinary excretion of methamphet amine is strongly dependent on urinary pH level. However, mice treated with 100 mg/kg maintained the baseline level of urinary pH. This finding indicates that the change in the urinary excretion of methamphetamine is scarcely involved in the interaction between R-THBP and methamphetamine. 50 mg/kg also failed to modify the effect of methamphetamine at 1 and 2 mg/kg. These results indicate that the enhancement of the ambulation-increasing effect of methamphet amine by R-THBP is produced when suf ficient amounts of the two drugs exist in the brain at the same time.
Methamphetamine is considered to cause the release of newly synthesized, but not stor ed, catecholamines, in particular dopamine, because the central stimulant effect is blocked by pretreatment with a-methyl-p-tyrosine, but not with reserpine (24, 25) . It is therefore postulated that R-THBP enhances the meth amphetamine effect through its action as a co-factor for tyrosine hydroxylase, i.e., elicit ing an enhancement of catecholamine syn thesis. In agreement with this consideration, R-THBP enhanced the ambulation-increasing effect of ephedrine, which is thought to show a similar neurochemical action to metham phetamine (24) .
It is also noteworthy that pretreatment with R-THBP at 100 mg/kg hardly modified the ambulation -increasing effect of cocaine, mazindol, bromocriptine, morphine and scopolamine. In our pilot study, R-THBP was ineffective to modify the ambulation-in creasing effect of apomorphine and methyl phenidate in dd strain mice (H. Kuribara, unpublished data). Cocaine and mazindol inhibit reuptake of catecholamines at presy naptic terminals (25, 26) . Methylphenidate releases catecholamines from storage sites, which is sensitive to reserpine but insensitive to a-methyl-p-tyrosine (24, 25) . Bromocrip tine and apomorphine directly stimulate post synaptic dopamine receptors (27, 28). Cate cholaminergic systems are indirectly stimulat ed through agonistic action on opioid re ceptors by morphine (29) and antagonistic action on muscarinic-cholinergic systems by scopolamine (30). Lee and Mandel (31) demonstrated that repeated dosing of amphet amine decreased the THBP level in the rat whole brain, while Brautigam et al. (32) re ported that apomorphine produced no signifi cant change in THBP level in the corpus striatum. These neurochemical data are con sistent with our results that R-THBP enhances the ambulation-increasing effect of metham phetamine, but not those of bromocriptine and apomorphine.
The effects of methamphetamine and co caine on animal behaviors, particularly on ambulatory activity, are quite similar to each other. It is therefore noteworthy that the behavioral characteristics of methamphet amine and cocaine can be differentiated by using R-THBP.
When methamphetamine is repeatedly ad ministered to the mouse, the ambulation increasing effect is progressively enhanced, showing reverse tolerance (33). The present experiment also confirmed the reverse toler ance to methamphetamine in the saline treated control group. It is, however, notable that although R-THBP at 100 mg/kg en hanced the effect of methamphetamine in the 1st and 2nd administration in the combined repeated administration regimen, the effect was abolished in the 3rd and later dosing. The ambulatory activity counts in the 3rd-5th administration were almost comparable be tween R-THBP-treated and saline-treated groups. However, the mechanism is not eluci dated yet, and further investigations are re quired.
